Intermediate for Tofacitinib. Tofacitinib (trade name Xeljanz, Jakvinus) is a janus kinase (JAK) inhibitor for the treatment of rheumatoid arthritis (RA). Tofacitinib has been approved by the U.S Food and Drug Administration in November 2012.


Product Name:                  N-Methyl-N-((3R,4R)-4-methylpiperidin-3-yl)-7H-pyrrolo[2,3-d]pyrimidin-4-amine

Synonyms:                         N/A

CAS Number:                     477600-74-1

Molecular Weight:            245.3266

Molecular Formula:          C13H19N5

Purity (HPLC):                     ≥95%

Shipping Conditions:         Room temperature.

Storage Conditions:           Refrigerated.

Regulatory Statement:      For Research Use Only.

SMILES:                               C[C@@H]1CCNC[C@@H]1N(c1ncnc2c1cc[nH]2)C

  • $346.00
  • Ex Tax: $346.00

Available Options